{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:43:22Z","timestamp":1771260202441,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T00:00:00Z","timestamp":1679184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T00:00:00Z","timestamp":1679184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013115","name":"Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013115","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12185-023-03581-3","type":"journal-article","created":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T18:02:43Z","timestamp":1679248963000},"page":"394-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes"],"prefix":"10.1007","volume":"118","author":[{"given":"Suying","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1789-0105","authenticated-orcid":false,"given":"Weiying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,19]]},"reference":[{"issue":"1","key":"3581_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5045\/br.2018.53.1.74","volume":"53","author":"T Vig","year":"2018","unstructured":"Vig T, Kodiatte TA, Manipadam MT, Aboobacker FN. A rare case of splenic diffuse red pulp small B-cell lymphoma (SDRPL): a review of the literature on primary splenic lymphoma with hairy cells. Blood Res. 2018;53(1):74\u20138.","journal-title":"Blood Res"},{"key":"3581_CR2","unstructured":"International Agency for Research on Cancer; World Health Organization. WHO Classification of Tumours of Haematopoieticand Lymphoid Tissues; International Agency for Research on Cancer: Lyon, France, 2008."},{"key":"3581_CR3","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","DOI":"10.1038\/s41375-022-01620-2"},{"issue":"2","key":"3581_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12185-018-02566-x","volume":"109","author":"RC Wang","year":"2019","unstructured":"Wang RC, Medeiros LJ, Chang KC. Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration. Int J Hematol. 2019;109(2):133\u20134.","journal-title":"Int J Hematol"},{"issue":"4","key":"3581_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/1516-3180.2016.0035130416","volume":"134","author":"MN Kerbauy","year":"2016","unstructured":"Kerbauy MN, Fernandes CM, Bezerra ED, Lage LA, Siqueira SA, Pereira J. Splenic diffuse red-pulp small B-cell lymphoma associated with hepatitis B virus: a report of two cases. Sao Paulo Med J. 2016;134(4):359\u201365.","journal-title":"Sao Paulo Med J"},{"issue":"Suppl","key":"3581_CR6","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/j.clml.2016.03.011","volume":"16","author":"HL Julhakyan","year":"2016","unstructured":"Julhakyan HL, Al-Radi LS, Moiseeva TN, Danishyan KI, Kovrigina AM, Glebova SM, et al. A single-center experience in splenic diffuse red pulp lymphoma diagnosis. Clin Lymphoma Myeloma Leuk. 2016;16(Suppl):S166\u20139.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"3581_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","volume":"95","author":"G Kanellis","year":"2010","unstructured":"Kanellis G, Mollejo M, Montes-Moreno S, Rodriguez-Pinilla SM, Cigudosa JC, Algara P, et al. Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica. 2010;95(7):1122\u20139.","journal-title":"Haematologica"},{"issue":"5","key":"3581_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/pin.12909","volume":"70","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Miyoshi H, Shimono J, Kawamoto K, Arakawa F, Furuta T, et al. Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma. Pathol Int. 2020;70(5):280\u20136.","journal-title":"Pathol Int"},{"issue":"6","key":"3581_CR9","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.3390\/curroncol28060431","volume":"28","author":"E Yilmaz","year":"2021","unstructured":"Yilmaz E, Chhina A, Nava VE, Aggarwal A. A review on splenic diffuse red pulp small B-cell lymphoma. Curr Oncol. 2021;28(6):5148\u201354.","journal-title":"Curr Oncol"},{"issue":"4","key":"3581_CR10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/his.12179","volume":"63","author":"LS Mendes","year":"2013","unstructured":"Mendes LS, Attygalle A, Matutes E, Wotherspoon A. Annexin A1 expression in a splenic diffuse red pulp small B-cell lymphoma: report of the first case. Histopathology. 2013;63(4):590\u20133.","journal-title":"Histopathology"},{"issue":"3","key":"3581_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00277-016-2860-2","volume":"96","author":"K Ben Younes","year":"2017","unstructured":"Ben Younes K, Doghri R, Mrad K, Ben Romdhane N, Ben A-F. Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case. Ann Hematol. 2017;96(3):511\u20132.","journal-title":"Ann Hematol"},{"issue":"10","key":"3581_CR12","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3324\/haematol.2016.160192","volume":"102","author":"L Jallades","year":"2017","unstructured":"Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, et al. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica. 2017;102(10):1758\u201366.","journal-title":"Haematologica"},{"issue":"8","key":"3581_CR13","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1182\/blood-2016-11-751024","volume":"129","author":"S Curiel-Olmo","year":"2017","unstructured":"Curiel-Olmo S, Mond\u00e9jar R, Almaraz C, Mollejo M, Cereceda L, Mar\u00e8s R, et al. Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood. 2017;129(8):1042\u20135.","journal-title":"Blood"},{"issue":"71","key":"3581_CR14","first-page":"253","volume":"13","author":"A Traverse-Glehen","year":"2012","unstructured":"Traverse-Glehen A, Baseggio L, Salles G, Coiffier B, Felman P, Berger F. Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity. Discov Med. 2012;13(71):253\u201365.","journal-title":"Discov Med"},{"issue":"2","key":"3581_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/PAS.0000000000000523","volume":"40","author":"D Martinez","year":"2016","unstructured":"Martinez D, Navarro A, Martinez-Trillos A, Molina-Urra R, Gonzalez-Farre B, Salaverria I, et al. NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease. Am J Surg Pathol. 2016;40(2):192\u2013201.","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"3581_CR16","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.3390\/ijms21165696","volume":"21","author":"S Milanesi","year":"2020","unstructured":"Milanesi S, Locati M, Borroni EM. Aberrant CXCR4 signaling at crossroad of WHIM Syndrome and Waldenstrom\u2019s Macroglobulinemia. Int J Mol Sci. 2020;21(16):5696.","journal-title":"Int J Mol Sci"},{"key":"3581_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.imlet.2019.11.007","volume":"217","author":"A Mousavi","year":"2020","unstructured":"Mousavi A. CXCL12\/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy. Immunol Lett. 2020;217:91\u2013115.","journal-title":"Immunol Lett"},{"key":"3581_CR18","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","volume":"11","author":"ME Bianchi","year":"2020","unstructured":"Bianchi ME, Mezzapelle R. The chemokine receptor CXCR4 in cell proliferation and tissue regeneration. Front Immunol. 2020;11:2109.","journal-title":"Front Immunol"},{"key":"3581_CR19","doi-asserted-by":"publisher","first-page":"963689721105449","DOI":"10.1177\/09636897211054498","volume":"30","author":"HR Bidkhori","year":"2021","unstructured":"Bidkhori HR, Bahrami AR, Farshchian M, Heirani-Tabasi A, Mirahmadi M, Hasanzadeh H, et al. Mesenchymal stem\/stromal cells overexpressing CXCR4R334X revealed enhanced migration: a lesson learned from the pathogenesis of WHIM syndrome. Cell Transplant. 2021;30:9636897211054498.","journal-title":"Cell Transplant"},{"issue":"2","key":"3581_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41375-020-01102-3","volume":"35","author":"LM Kaiser","year":"2021","unstructured":"Kaiser LM, Hunter ZR, Treon SP, Buske C. CXCR4 in Waldenstr\u00f6m\u2019s Macroglobulinema: chances and challenges. Leukemia. 2021;35(2):333\u201345.","journal-title":"Leukemia"},{"issue":"2","key":"3581_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7150\/thno.21397","volume":"8","author":"S Habringer","year":"2018","unstructured":"Habringer S, Lapa C, Herhaus P, Schottelius M, Istvanffy R, Steiger K, et al. Dual targeting of acute leukemia and supporting Niche by CXCR4-directed theranostics. Theranostics. 2018;8(2):369\u201383.","journal-title":"Theranostics"},{"issue":"7","key":"3581_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/RLI.0000000000000469","volume":"53","author":"ME Mayerhoefer","year":"2018","unstructured":"Mayerhoefer ME, Jaeger U, Staber P, Raderer M, Wadsak W, Pfaff S, et al. [68Ga]Ga-Pentixafor PET\/MRI for CXCR4 imaging of chronic lymphocytic leukemia: preliminary results. Invest Radiol. 2018;53(7):403\u20138.","journal-title":"Invest Radiol"},{"key":"3581_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710900","volume":"11","author":"T Juntikka","year":"2021","unstructured":"Juntikka T, Vaittinen S, Vahlberg T, Jyrkki\u00f6 S, Minn H. Somatostatin receptors and chemokine receptor cxcr4 in lymphomas: a histopathological review of six lymphoma subtypes. Front Oncol. 2021;11: 710900.","journal-title":"Front Oncol"},{"key":"3581_CR24","first-page":"3276925","volume":"2022","author":"YA Zhang","year":"2022","unstructured":"Zhang YA, Yang X, Yao J, Ren Y, Liu P. Identification of CXCR4 upregulation in diffuse large B-cell lymphoma associated with prognostic significance and clinicopathological characteristics. Dis Markers. 2022;2022:3276925.","journal-title":"Dis Markers"},{"issue":"11","key":"3581_CR25","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/exd.14365","volume":"30","author":"J Danis","year":"2021","unstructured":"Danis J, Kelemen E, Rajan N, Nagy N, Sz\u00e9ll M, \u00c1d\u00e1m \u00c9. TRAF3 and NBR1 both influence the effect of the disease-causing CYLD(Arg936X) mutation on NF-\u03baB activity. Exp Dermatol. 2021;30(11):1705\u201310.","journal-title":"Exp Dermatol"},{"issue":"19","key":"3581_CR26","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1182\/bloodadvances.2020003597","volume":"5","author":"L Zhou","year":"2021","unstructured":"Zhou L, Zhang Y, Meads MB, Dai Y, Ning Y, Hu X, et al. IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-\u03baB- and caspase-8-dependent mechanisms. Blood Adv. 2021;5(19):3776\u201388.","journal-title":"Blood Adv"},{"key":"3581_CR27","doi-asserted-by":"crossref","unstructured":"Perez-Chacon G, Adrados M, Vallejo-Cremades MT, Lefebvre S, Reed JC, Zapata JM. Dysregulated TRAF3 and BCL2 expression promotes multiple classes of mature Non-hodgkin B cell lymphoma in Mice. Front Immunol. 201;9:3114.","DOI":"10.3389\/fimmu.2018.03114"},{"issue":"7","key":"3581_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/ajh.26578","volume":"97","author":"C P\u00e9rez-Carretero","year":"2022","unstructured":"P\u00e9rez-Carretero C, Hern\u00e1ndez-S\u00e1nchez M, Gonz\u00e1lez T, Quijada-\u00c1lamo M, Mart\u00edn-Izquierdo M, Santos-M\u00ednguez S, et al. TRAF3 alterations are frequent in del-3\u2019IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features. Am J Hematol. 2022;97(7):903\u201314.","journal-title":"Am J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03581-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03581-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03581-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T05:11:28Z","timestamp":1702098688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03581-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,19]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3581"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03581-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,19]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study passed the ethical review (Ethics Clearance No.008).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}